STOCK TITAN

VERSES Issues Inaugural Monthly Newsletter May 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
VERSES AI (CBOE: VERS, OTCQB: VRSSF) has launched its inaugural monthly newsletter, highlighting significant company developments. The company recently launched Genius™, its enterprise AI platform, on April 30th, 2025, targeting machine learning and data science professionals. The platform offers domain-specific models for predictive decision-making across various sectors including telecom, logistics, and healthcare. A notable use case demonstrates Genius's potential in diabetes management through intelligent insulin delivery optimization. The company reported substantial research progress, with multiple papers accepted at prestigious conferences and publications. Key corporate updates include the promotion of Lori Pike to VP of Engineering, Tim Bellay to Director of Product, James Hendrickson to President and COO, and the appointment of James Christodoulou as CFO. VERSES recently completed a US$7.9 million public offering and is preparing for a planned NASDAQ uplisting.
VERSES AI (CBOE: VERS, OTCQB: VRSSF) ha lanciato la sua prima newsletter mensile, evidenziando importanti sviluppi aziendali. L'azienda ha recentemente presentato Genius™, la sua piattaforma AI enterprise, il 30 aprile 2025, rivolta a professionisti del machine learning e della data science. La piattaforma offre modelli specifici per settore per supportare decisioni predittive in ambiti come telecomunicazioni, logistica e sanità. Un caso d'uso significativo mostra il potenziale di Genius nella gestione del diabete attraverso l'ottimizzazione intelligente della somministrazione di insulina. L'azienda ha riportato notevoli progressi nella ricerca, con numerosi articoli accettati in conferenze e pubblicazioni di rilievo. Tra gli aggiornamenti aziendali chiave vi sono la promozione di Lori Pike a VP of Engineering, Tim Bellay a Director of Product, James Hendrickson a Presidente e COO, e la nomina di James Christodoulou a CFO. VERSES ha recentemente completato un'offerta pubblica da 7,9 milioni di dollari e si sta preparando per la quotazione prevista al NASDAQ.
VERSES AI (CBOE: VERS, OTCQB: VRSSF) ha lanzado su primer boletín mensual, destacando desarrollos importantes de la compañía. Recientemente, la empresa presentó Genius™, su plataforma de IA empresarial, el 30 de abril de 2025, dirigida a profesionales de aprendizaje automático y ciencia de datos. La plataforma ofrece modelos específicos por dominio para la toma de decisiones predictivas en sectores como telecomunicaciones, logística y salud. Un caso de uso destacado demuestra el potencial de Genius en la gestión de la diabetes mediante la optimización inteligente de la administración de insulina. La empresa reportó avances significativos en investigación, con varios artículos aceptados en conferencias y publicaciones prestigiosas. Las actualizaciones corporativas clave incluyen el ascenso de Lori Pike a VP de Ingeniería, Tim Bellay a Director de Producto, James Hendrickson a Presidente y COO, y el nombramiento de James Christodoulou como CFO. VERSES completó recientemente una oferta pública de 7,9 millones de dólares y se prepara para una próxima cotización en NASDAQ.
VERSES AI(CBOE: VERS, OTCQB: VRSSF)는 중요한 회사 소식을 담은 첫 월간 뉴스레터를 발행했습니다. 회사는 2025년 4월 30일 머신러닝 및 데이터 과학 전문가를 대상으로 하는 기업용 AI 플랫폼 Genius™를 출시했습니다. 이 플랫폼은 통신, 물류, 헬스케어 등 다양한 분야에서 예측 의사결정을 위한 도메인 특화 모델을 제공합니다. 특히 Genius가 지능형 인슐린 투여 최적화를 통해 당뇨병 관리에 활용되는 사례가 주목받고 있습니다. 회사는 권위 있는 학회와 출판물에 다수의 연구 논문이 채택되는 등 연구 성과도 크게 향상되었습니다. 주요 인사 소식으로는 Lori Pike가 엔지니어링 부사장으로, Tim Bellay가 제품 이사로, James Hendrickson이 사장 겸 COO로, James Christodoulou가 CFO로 임명되었습니다. VERSES는 최근 790만 달러 규모의 공개 모집을 완료했으며, NASDAQ 상장을 준비 중입니다.
VERSES AI (CBOE : VERS, OTCQB : VRSSF) a lancé sa première newsletter mensuelle, mettant en avant des développements importants de l'entreprise. La société a récemment lancé Genius™, sa plateforme d'IA d'entreprise, le 30 avril 2025, destinée aux professionnels du machine learning et de la data science. La plateforme propose des modèles spécifiques à chaque domaine pour la prise de décision prédictive dans divers secteurs tels que les télécommunications, la logistique et la santé. Un cas d'utilisation notable illustre le potentiel de Genius dans la gestion du diabète grâce à l'optimisation intelligente de l'administration d'insuline. L'entreprise a annoncé des progrès significatifs en recherche, avec plusieurs articles acceptés dans des conférences et publications prestigieuses. Parmi les mises à jour clés, on compte la promotion de Lori Pike au poste de VP Engineering, Tim Bellay en tant que directeur produit, James Hendrickson comme président et COO, ainsi que la nomination de James Christodoulou au poste de CFO. VERSES a récemment finalisé une offre publique de 7,9 millions de dollars et se prépare à une introduction en bourse prévue au NASDAQ.
VERSES AI (CBOE: VERS, OTCQB: VRSSF) hat seinen ersten monatlichen Newsletter veröffentlicht, der bedeutende Unternehmensentwicklungen hervorhebt. Das Unternehmen brachte am 30. April 2025 seine Unternehmens-KI-Plattform Genius™ auf den Markt, die sich an Fachleute im Bereich maschinelles Lernen und Datenwissenschaft richtet. Die Plattform bietet domänenspezifische Modelle für prädiktive Entscheidungsfindung in verschiedenen Branchen wie Telekommunikation, Logistik und Gesundheitswesen. Ein bemerkenswertes Anwendungsbeispiel zeigt das Potenzial von Genius bei der Diabetesbehandlung durch intelligente Optimierung der Insulinabgabe. Das Unternehmen meldete erhebliche Forschungserfolge mit mehreren auf renommierten Konferenzen und Publikationen akzeptierten Fachartikeln. Wichtige Unternehmensneuigkeiten umfassen die Beförderung von Lori Pike zur VP Engineering, Tim Bellay zum Director of Product, James Hendrickson zum Präsidenten und COO sowie die Ernennung von James Christodoulou zum CFO. VERSES hat kürzlich eine öffentliche Kapitalerhöhung in Höhe von 7,9 Millionen US-Dollar abgeschlossen und bereitet sich auf eine geplante Notierung an der NASDAQ vor.
Positive
  • Commercial launch of Genius™ platform with consumption-based and enterprise pricing models
  • Multiple research papers accepted at prestigious conferences including ICLR 2025
  • Successful completion of US$7.9M (C$11.0M) public offering
  • Strategic expansion of leadership team and preparation for NASDAQ uplisting
  • Renewal of exclusive agreement with renowned neuroscientist Prof. Karl Friston
Negative
  • Continued reliance on public offerings for funding
  • Product still in early commercialization phase with unproven market adoption

VERSES® is now trading on OTCQB:VRSSF and CBOE:VERS

VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”) is pleased to announce the launch of its inaugural monthly newsletter.

FROM THE CEO

Welcome to the inaugural issue of VERSES Monthly Newsletter. As the company grows, this newsletter is intended to offer a window into VERSES, highlighting our increasing momentum, product innovation, commercial traction, research breakthroughs, financial highlights, and the larger vision guiding us forward.

I believe this is an exhilarating moment for VERSES. The pace inside our labs and across our customer engagements continues to accelerate, and this newsletter reflects our commitment to keep you closely and consistently informed. Look for highlights on Genius releases, new partnerships, media coverage, events, and milestones that showcase the value we expect to create together.

Thank you for your interest and support. We’re excited to welcome you aboard and are looking forward to sharing our journey with you.

Sincerely,

Gabriel René

Founder and CEO of VERSES

PRODUCT UPDATE

Genius

Genius officially launched on April 30th, enabling Agentic Intelligence for Enterprise. The initial target audience for Genius is machine learning and data science professionals trying to solve enterprise problems that require prediction with uncertainty or hidden factors. Genius is designed to provide the tools necessary to build domain-specific models that are intended to enhance decision-making (inference as a service) for third-party agents through our SDKs/APIs and model editor.

Genius’ launch comes with significant upgrades and enhancements based on extensive testing and feedback from customers during the beta phase. Users and partners across several industry sectors including telecomlogisticsoil and gas exploration and more provided valuable insight into building domain-specific models and generating reliable predictions. Updates were made to the model editor, application programming interfaces (APIs) and a customer portal to manage deployments and licenses, monitor system performance, and request support and new features. A full list of models, capabilities and pricing can be found on our website https://www.verses.ai/genius. Genius is now a paid service with consumption-based and performance-based pricing as well as enterprise licensing.

USE CASE SPOTLIGHT

We look forward to sharing many of our commercial examples, demos, customer announcements and testimonials. In this month’s Use Case Spotlight we show how Genius can have a real impact in Healthcare, specifically for insulin delivery optimization. Diabetes management today relies on automated insulin pumps or manual injections, both of which lack the ability to adapt to individual patient behaviors—like irregular meals, exercise intensity, or stress levels. Current solutions use static predictive models, leading to frequent hypo/hyperglycemic events.

With Genius healthcare providers and device manufacturers could embed active inference agents within insulin pumps that can:

  • Learn patient-specific glucose response patterns over time.
  • Adapt insulin delivery in real-time based on data from a continuous glucose monitor (CGM).
  • Improve patient safety with predictive crash avoidance, reducing emergency incidents.
  • Lower healthcare costs by better managing chronic care.

According to the International Diabetes Federation Diabetes Atlas (2025) there are 589 million adults (20-79 years) living with diabetes globally and this number is predicted to rise to 853 million by 2050. Diabetes was responsible for 3.4 million deaths in 2024 – 1 every 9 seconds and estimated to have caused at least USD 1 trillion dollars in health expenditure – a 338% increase over the last 17 years.

Diabetes Federation

The prediction and decision making capabilities that Genius is designed to provide can be applied to many domains and use cases that have high degrees of volatility, uncertainty, complexity or ambiguity such as:

  • Consumer Demand Predictions and Recommendations.  Consumer trends change, frequently and almost unpredictably. Reasoning and helping make inventory decisions in real time to meet consumer demand
  • Clinical Trial Predictions.  Outcomes are highly unpredictable despite best practices — human biology has too many unknowns. Investments hinge on uncertain regulatory and trial outcomes.
  • Global Supply Chain Optimization.  Thousands of interdependent suppliers create compounding effects even from small disruptions. Tracking cause and effect in a global network is extremely difficult.

RESEARCH DEVELOPMENTS

Research and development is advancing steadily including progress on benchmarks. At the end of 2024, we shared information regarding our progress on several games and since then have formulated a more comprehensive framework designed to address current challenges and showcase intricate scenarios that require advanced strategies, with results expected in the near future. In March 2025, at the AI UK 2025 event held at the Turing Institute we presented EcoNet, an active inference-based multi-agent simulation, which focuses on urban energy optimization.

So far this year, many of our employees, known as VERSIANS, have published and preprinted several scholarly papers.

Finally, we expect that later this month, we will be able to share a much anticipated update on the “Atari Benchmark,” results, their third-party validation, its associated research paper and submission to NeurIPS for peer review and publishing, and its implications for Genius and the future of the AI Industry.

KARL’S CORNER

Professor Karl Friston, world renowned neuroscientist recognized for the Free Energy Principle and Active Inference, has served as our Chief Scientist since December 2022, leading our AI research efforts.

In December 2024, VERSES renewed its exclusive agreement with Professor Friston, extending his role to continue to advance the research behind our flagship product, Genius™, a suite of tools designed to model complex dynamic systems that continuously reason, plan, and learn.

Prof Friston was invited to give a keynote lecture at the first workshop on NeuroAI at NeurIPS 24 NeurIPS Keynote 1, with a subsequent panel discussion NeurIPS Panel Discussion — with Yoshua Bengio — on the fusion of neuroscience and artificial intelligence for intelligent solutions for our future. A more intuitive introduction to the underlying principles can be found in Professor Friston's lecture entitled, “How the Brain Makes Predictions.”

Karl Friston

Last month, Professor Friston and VERSES Research Lab co-authored a paper titled “Agentic rulebooks using active inference: An artificial intelligence application for environmental sustainability”. A neuroscience-inspired AI approach could make smart thermostats more adaptable, helping balance energy costs, user comfort, and grid demands, even in extreme conditions. This work was showcased at The Alan Turing Institute’s showcase, AI UK 2024. Other notable authors are University of Sussex, Université du Québec à Montréal, Pennsylvania State University (PSU) and Wellcome Centre for Human Neuroimaging, University College London.

On the launch of Genius, Professor Friston commented, “I’m incredibly delighted and impressed with the state of Genius. It’s like watching a pipe-dream come to life. I was particularly taken with the care and attention the team has paid to making Active Inference more accessible and the potential applications now suddenly came into sharp and exciting focus.”

CORPORATE NEWS

We’re thrilled to announce the promotions of Lori Pike to Vice President of Engineering and Tim Bellay to Director of Product—two key leaders whose dedication has been instrumental in keeping the launch of Genius on track. Lori’s technical leadership and ability to scale high-performing teams have been foundational to our engineering success, while Tim’s strategic product vision and user-first mindset have shaped a roadmap that meets market needs with precision. Their continued leadership will be critical as we scale.

These promotions follow two recently announced important leadership updates: James Hendrickson was appointed President and Chief Operating Officer, expanding his role as he continues to drive operational excellence across the organization. Since joining VERSES, James has played a critical role in scaling our operations and aligning teams to execute on our strategic vision—his expanded title reflects his growing impact on the business. Additionally, we welcomed James Christodoulou as Chief Financial Officer. With a strong background in public company finance and strategic capital management, James (known at Verses as JC) will lead our financial operations as we prepare for the next phase of growth.

AI SECTOR UPDATE

NVIDIA held its GTC AI Conference in San Jose, California. This year’s event was completely sold out, with an estimated 20,000 investors, engineers, and business leaders in attendance.

NVIDIA CEO Jensen Huang described a future where AI agents will transform entire industries, making businesses more efficient, aerospace and defense more advanced, and markets more intelligent.

Huang spoke extensively about “agentic AI,” or AI that doesn’t just retrieve data but perceives, reasons, and acts on your behalf. Here is where NVIDIA thinks AI agents are on the AI adoption curve. 

AI Trends

Morgan Stanley highlighted its 5 AI Trends at its Technology, Media & Telecom Conference in San Francisco on March 5, 2025.

  1. AI reasoning and custom silicon fuel demand for chips
  2. Hyperscalers see cloud migrations and AI workloads as revenue opportunities
  3. LLMs see potential in AI reasoning for enterprises
  4. Data companies zero in on evaluating AI
  5. Software companies set sights on agentic AI

NEWS AND KEY MOMENTS

Apr 30, 2025 VERSES® Announces Commercial Launch of Genius™

Apr 28, 2025 VERSES® Announces Closing of US$7.9 Million (C$11.0 Million) Public Offering

Apr 24, 2025 VERSES® Announces Pricing of Public Offering of Units

Apr 24, 2025 VERSES® Announces Proposed Public Offering of Securities

Apr 17, 2025 VERSES® Promotes James Hendrickson to President and Chief Operating Officer

Mar 28, 2025 VERSES® Trading Under New Ticker VRSSD on OTCQB Market

Mar 26, 2025 VERSES® Announces Consolidation of Class A Subordinate Voting Shares in Preparation for a Planned Uplisting to NASDAQ

Mar 21, 2025 VERSES® Announces Commercial Partnership with AI Driller for Smarter Oil and Gas Operations

Mar 18, 2025 VERSES Demonstrates Smart Building Energy Optimization

Mar 7, 2025 VERSES® to Present at the 37th Annual Roth Conference March 16-18th

Mar 4, 2025 VERSES® Announces Conversion of Strategic Investment by G42

Feb 27, 2025 VERSES® Appoints Public Market Veteran James Christodoulou as Chief Financial Officer

Feb 25, 2025 VERSES® Announces Launch of Commercial Genius™ Agent Toolkit

Feb 7, 2025 VERSES® Announces Fireside Chat with Chief Scientist Professor Karl Friston

Feb 4, 2025 VERSES® Genius™ Outperforms DeepSeek R1 Model in Code-Breaking “Mastermind” Challenge

Jan 30, 2025 VERSES® Partners with Leading Global Investment Firm for Genius™ Beta

Jan 27, 2025 VERSES® Partners with Top Australian Telecom for Genius™ Beta

Jan 22, 2025 VERSES Genius™ Agent Outperforms Leading AI Algorithms at Major Industry Benchmark

Jan 13, 2025 VERSES to Release Atari Benchmark Results at World Economic Forum in Davos

Jan 9, 2025 VERSES Announces Closing of First Tranche of LIFE Private Placement Offering

Jan 9, 2025 VERSES Announces Closing of US$13.9 Million (C$20.0 Million) Prospectus Supplement Offering

Jan 7, 2025 VERSES AI Announces Pricing of Unit Offering


About VERSES

VERSES is a cognitive computing company building next-generation intelligent software systems modeled after the wisdom and genius of Nature. Designed around first principles found in science, physics and biology, our flagship product, Genius,™ is a suite of tools for machine learning practitioners to model complex dynamic systems and generate autonomous intelligent agents that continuously reason, plan, and learn. Imagine a Smarter World that elevates human potential through technology inspired by Nature. Learn more at verses.aiLinkedIn and X

On Behalf of the Company

Gabriel René VERSES AI Inc.
Co-Founder & CEO

Investor Relations and Media Inquiries

James Christodoulou
Chief Financial Officer
Verses AI Inc.
IR@Verses.ai
(212) 970-8889

FORWARD LOOKING DISCLAIMER

Certain information included in this newsletter contains statements that are forward-looking, such as statements related to our flagship product, Genius, the commercial application of Genius and our research developments, as well as developments in the AI sector. Such forward looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and accordingly, such results may differ materially from those expressed in any forward looking statements made by or on behalf of VERSES.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/f43120ed-7e29-460c-812a-c5c8b383ef38

https://www.globenewswire.com/NewsRoom/AttachmentNg/4ff364c2-cd6d-409e-b1a1-70aca034b1d3

https://www.globenewswire.com/NewsRoom/AttachmentNg/b78d70fd-b992-42bd-8f5c-aa85df39eced

https://www.globenewswire.com/NewsRoom/AttachmentNg/517ab4cf-ae68-4099-8fb1-b0c7971d0d03


FAQ

What is VERSES AI's Genius platform and when was it launched?

VERSES AI's Genius is an enterprise AI platform launched on April 30th, 2025, designed to provide tools for building domain-specific models that enhance decision-making through inference as a service. It targets machine learning and data science professionals and offers consumption-based and enterprise licensing options.

How much did VERSES AI (VRSSF) raise in their latest public offering?

VERSES AI completed a public offering of US$7.9 million (C$11.0 million) as announced on April 28th, 2025.

Who are the key executives in VERSES AI's leadership team?

Key executives include Gabriel René as Founder and CEO, James Hendrickson as President and COO, James Christodoulou as CFO, Lori Pike as VP of Engineering, Tim Bellay as Director of Product, and Professor Karl Friston as Chief Scientist.

What is VERSES AI's plan for stock market listing?

VERSES AI currently trades on CBOE (VERS) and OTCQB (VRSSF), and has announced preparations for a planned uplisting to NASDAQ, including a consolidation of Class A Subordinate Voting Shares.

How is VERSES AI applying their Genius platform in healthcare?

VERSES AI is applying Genius in healthcare through insulin delivery optimization, using active inference agents within insulin pumps to learn patient-specific glucose patterns, adapt insulin delivery in real-time, and improve patient safety through predictive crash avoidance.
VERSES AI INC

OTC:VRSSF

VRSSF Rankings

VRSSF Latest News

VRSSF Stock Data

148.56M
19.20M
48.99%
0.01%
Software - Infrastructure
Technology
Link
Canada
New Westminster